ID   MA01
AC   CVCL_C341
SY   MA 01; Ma01; ACTe001-A
DR   hPSCreg; ACTe001-A
DR   ISCR; 135
DR   SKIP; SKIP001923
DR   Wikidata; Q54903874
RX   Patent=US10072243;
RX   PubMed=16929302;
RX   PubMed=18713948;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-38(1).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
RX   Patent=US10072243;
RA   Chung Y.-G., Lanza R.P., Klimanskaya I.V.;
RT   "Derivation of embryonic stem cells and embryo-derived cells.";
RL   Patent number US10072243, 11-Sep-2018.
//
RX   PubMed=16929302; DOI=10.1038/nature05142;
RA   Klimanskaya I.V., Chung Y.-G., Becker S., Lu S.-J., Lanza R.P.;
RT   "Human embryonic stem cell lines derived from single blastomeres.";
RL   Nature 444:481-485(2006).
//
RX   PubMed=18713948; DOI=10.1182/blood-2008-05-157198;
RA   Lu S.-J., Feng Q., Park J.S., Vida L., Lee B.-S., Strausbauch M.,
RA   Wettstein P.J., Honig G.R., Lanza R.P.;
RT   "Biologic properties and enucleation of red blood cells from human
RT   embryonic stem cells.";
RL   Blood 112:4475-4484(2008).
//